期刊文献+

欧盟药品不良反应管理和上报指南简介 被引量:11

Introduction of Management and Reporting of Adverse Reactions to Medicinal Products in European Union
下载PDF
导出
摘要 通过对于欧盟药品不良反应管理和上报指南的介绍,进一步了解欧盟对药品不良反应定义、报告收集、报告确认、报告随访、数据管理、质量管理等不良反应管理流程,为完善和发展我国药品不良反应报告和监测工作提供借鉴和参考。 By introducing good pharmacovigilance prctice on management and reporting of adverse reactions to medicinal products in EU, it was more cleared to know the definition of adverse reactions and working process in EU, such ascollection of reports, validation of reports, follow-up of reports, data management, quality management. It provided the example and refrence for perfecting and developing drug adverse reaction reporting and monitoring system in China.
出处 《中国药物警戒》 2014年第10期611-613,617,共4页 Chinese Journal of Pharmacovigilance
关键词 欧盟 药物警戒 不良反应 管理 上报 European Union pharmacovigilance adverse reactions management reporting
  • 相关文献

参考文献6

  • 1European Medicines Agency. Pharmacovigilance legislation [EB/OL].(2014-01-01)[2014-07-28].http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000491.jsp&mid=WC0b01ac058058f32d.
  • 2董铎,吴桂枝,程刚.欧盟新法规下的药物警戒制度简介[J].中国药物警戒,2012,9(11):662-665. 被引量:23
  • 3European Medicines Agency.GVPModule VI Management and re-porting of adverse reactions to medicinal products [EB/OL].(2012-06-22) [ 2014-08-23 ]. http: //www. ema. europa. eu/docs/en_GB/document_Hbrary/Scientific__guideline/2012/06/WC500129135.pdf.
  • 4European Medicines Agency.IME list based on MedDRA version17.0 [EB/OL]. (2014-03-05)[2014-08-23].http://eudravigilance.ema.europa.eu/human/textforIME.asp.
  • 5European Medicines Agency.ICH Topic E 2 DPost Approval SafetyData Management[EB/OL].(2004-05-01)[2014-08-23]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guide-line/2009/09AVC500002807.pdf.
  • 6European Medicines Agency.Inclusion/exclusion criteria for the"Important Medical Events" list[EB/OL]. (2014-03-05)[2014-08-23].http://eudravigilance.ema.europa.eu/human/docs/IME/IME%20criteria%20vl7%200.doc.

二级参考文献20

  • 1European Commission. The EU pharmacovigilance system[EB/OL]. http://ec.europaeu/health/human-use/pharmacovigilance/index_en. htm#geninf( 2012-09-16 ).
  • 2Peter Arlett. New Pharmacovigilance legislation and focus on post-authorisation studies (2010-11-29)[EB/OL].www.diahome. org/.../24003/session%203_peter%20arlett.pdf (2012-9-16).
  • 3European Medicines Agency. 2010 pharmacovigilance legislation [EB/OL].http://www.ema.europa.eu/ema/index.j sp curl=pages/ regulation/general/general_content_000492.j sp&mid=WC0b01 ac 058033e8ad (2012-9-16).
  • 4European Medicines Agency. Commission Implementing Regula- tion (EU) No 520/2012 (2012-6-19)[EB/OL]. http://eurx.europa. eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:159:0005:0025: EN:PDF (2012-9-16).
  • 5European Medicines Agency. Good Pharmacovigilance Practices [ EB/OL ]. http://www, ema. europa, eu/ema/index .j sp curl=pages/ regulation/document_listing/document_listing_000345. j sp&mid=WC0b01 ac058058f32c ( 2012-9-16 ).
  • 6European Medicines Agency. GVP Module I Pharmacovigilance Systems and their Quality Systems (2012-6-22) [EB/OL].http:// www.ema.europa.eu/docs/en_GB/document_library/Scientif- ic_guideline/2012/06/WC500129132.pdf( 2012-09-17 ).
  • 7European Medicines Agency. GVP Module II Pharmacovigilance System Master File(2012-6-22 ) [EB/OL].http://www.ema.europa. eu/docs/en GB/document_library/Scientific_guideline/2012/06/ WCS00129133.pdf(2012-09-17).
  • 8European Medicines Agency. GVP Module III Pharmacovigilance Inspections( 2012-6-22 ) [EB/OL] .http://www.ema.europa.eu/docs/en_ GB/document_library/Scientific_guideline/2012/06/WC500129243. pdf(2012-09-17).
  • 9European Medicines Agency. GVP Module V- Risk Management Systems( 2012-6-22 )[EB/OL].http://www.ema.europa.eu/docs/en_ GB/document_library/Scientific_guideline/2012/06/WC500129134. pdf(2012-9-18).
  • 10European Medicines Agency. GVP Module VI - Management and Reporting of Adverse Reactions to Medicinal Products( 2012-06- 22) [EB/OL].http://www.ema.europa.eu/docs/en_GB/document_ library/Scientific_guideline/2012/06/WC500129135.pdf( 2012- 09-18).

共引文献22

同被引文献128

引证文献11

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部